Date Name Title Filing Type Shares Traded Price Total Held
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 194,854 -- --
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 333,000 -- 70,000
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 70,000 -- --
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 263,000 -- --
Jan 03, 2005
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Jan 03, 2005
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Jan 03, 2005
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000
Jan 03, 2005
SVP Fin & Admin, CFO, & Treas
SVP Fin & Admin, CFO, & Treas Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,800 $5.62 38,127
Jan 03, 2005
SVP Fin & Admin, CFO, & Treas
SVP Fin & Admin, CFO, & Treas Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,800 -- --
Jan 03, 2005
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 -- 15,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.